Skip to main content
PMC home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1967 Jul;58(1):81–88. doi: 10.1073/pnas.58.1.81

An adrenergic control system in Tetrahymena.

J J Blum
PMCID: PMC335600  PMID: 4382515

Full text

PDF
81

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BLACK J. W., CROWTHER A. F., SHANKS R. G., SMITH L. H., DORNHORST A. C. A NEW ADRENERGIC BETARECEPTOR ANTAGONIST. Lancet. 1964 May 16;1(7342):1080–1081. doi: 10.1016/s0140-6736(64)91275-9. [DOI] [PubMed] [Google Scholar]
  2. BRODIE B. B., ARONOW L., AXELROD J. The fate of dibenzyline in the body and the role of fat in its duration of action. J Pharmacol Exp Ther. 1954 May;111(1):21–29. [PubMed] [Google Scholar]
  3. BUTCHER R. W., SUTHERLAND E. W. Adenosine 3',5'-phosphate in biological materials. I. Purification and properties of cyclic 3',5'-nucleotide phosphodiesterase and use of this enzyme to characterize adenosine 3',5'-phosphate in human urine. J Biol Chem. 1962 Apr;237:1244–1250. [PubMed] [Google Scholar]
  4. Blum J. J., Kirshner N., Utley J. The effect of reserpine on growth and catecholamine content of Tetrahymena. Mol Pharmacol. 1966 Nov;2(6):606–608. [PubMed] [Google Scholar]
  5. Brodie B. B., Davies J. I., Hynie S., Krishna G., Weiss B. Interrelationships of catecholamines with other endocrine systems. Pharmacol Rev. 1966 Mar;18(1):273–289. [PubMed] [Google Scholar]
  6. Butcher R. W. Cyclic 3',5'-AMP and the lipolytic effects of hormones on adipose tissue. Pharmacol Rev. 1966 Mar;18(1):237–241. [PubMed] [Google Scholar]
  7. Cline S. G., Conner R. L. Orthophosphate excretion as related to RNA metabolism in Tetrahymena. J Cell Physiol. 1966 Oct;68(2):149–156. doi: 10.1002/jcp.1040680209. [DOI] [PubMed] [Google Scholar]
  8. Haugaard N., Hess M. E. The influence of catecholamines on heart function and phosphorylase activity. Pharmacol Rev. 1966 Mar;18(1):197–203. [PubMed] [Google Scholar]
  9. Helmreich E., Cori C. F. The activation of glycolysis in frog sartorius muscle by epinephrine. Pharmacol Rev. 1966 Mar;18(1):189–196. [PubMed] [Google Scholar]
  10. Hornbrook K. R., Quinn P. V., Siegel J. H., Brody T. M. Thyroid hormone regulation of cardiac glycogen metabolism. Biochem Pharmacol. 1965 Jun;14(6):925–936. doi: 10.1016/0006-2952(65)90244-3. [DOI] [PubMed] [Google Scholar]
  11. Janakidevi K., Dewey V. C., Kidder G. W. Serotonin in protozoa. Arch Biochem Biophys. 1966 Mar;113(3):758–759. doi: 10.1016/0003-9861(66)90259-1. [DOI] [PubMed] [Google Scholar]
  12. Janakidevi K., Dewey V. C., Kidder G. W. The biosynthesis of catecholamines in two genera of protozoa. J Biol Chem. 1966 Jun 10;241(11):2576–2578. [PubMed] [Google Scholar]
  13. LEE W. C., SHIN W. H., SHIDEMAN F. E. Cardiac activities of several monoamine oxidase inhibitors. J Pharmacol Exp Ther. 1961 Aug;133:180–185. [PubMed] [Google Scholar]
  14. MURAD F., CHI Y. M., RALL T. W., SUTHERLAND E. W. Adenyl cyclase. III. The effect of catecholamines and choline esters on the formation of adenosine 3',5'-phosphate by preparations from cardiac muscle and liver. J Biol Chem. 1962 Apr;237:1233–1238. [PubMed] [Google Scholar]
  15. Obianwu H. O. The effect of prenylamine (segontin) on the amine levels of brain, heart and adrenal medulla in rats. Acta Pharmacol Toxicol (Copenh) 1965;23(4):383–390. doi: 10.1111/j.1600-0773.1965.tb00362.x. [DOI] [PubMed] [Google Scholar]
  16. TEDESCHI R. E., TEDESCHI D. H., AMES P. L., COOK L., MATTIS P. A., FELLOWS E. J. Some pharmacological observations on tranylcypromine (SKF trans-385), a potent inhibitor of monoamine oxidase. Proc Soc Exp Biol Med. 1959 Nov;102:380–381. doi: 10.3181/00379727-102-25256. [DOI] [PubMed] [Google Scholar]
  17. VANEYS J., WARNOCK L. G. THE INHIBITION OF MOTILITY OF CILIATES THROUGH METHONIUM DRUGS. J Protozool. 1963 Nov;10:465–467. doi: 10.1111/j.1550-7408.1963.tb01706.x. [DOI] [PubMed] [Google Scholar]
  18. WEIL-MALHERBE H., POSNER H. S., BOWLES G. R. Changes in the concentration and intracellular distribution of brain catecholamines: the effects of reserpine. beta-phenyliso-propylhydrazine, pyrogallol and 3,4-dihydroxyphenyl alanine, alone and in combination. J Pharmacol Exp Ther. 1961 Jun;132:278–286. [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES